Q32 Bio Inc.
QTTB
$6.30
-$0.52-7.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 506.86% | 58.01% | 44.11% | -1,172.01% | 47.58% |
| Total Depreciation and Amortization | -25.00% | -26.02% | -24.79% | -3.25% | -3.23% |
| Total Amortization of Deferred Charges | -24.49% | -8.00% | -25.76% | 65.52% | 63.33% |
| Total Other Non-Cash Items | -4,046.04% | 13.15% | 50.71% | 104.01% | -13.06% |
| Change in Net Operating Assets | -119.51% | 151.48% | 50.99% | -286.28% | -93.21% |
| Cash from Operations | 45.92% | 78.33% | 52.05% | 14.22% | -6.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 350,100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -117.94% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 317.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -592.74% | -256.77% | -- | -- | 317.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.32% | 32.51% | 40.32% | -114.70% | -4.46% |